The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment
BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2004/394710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551855154003968 |
|---|---|
| author | Shawn D Aaron Katherine Vandemheen Dean Fergusson Mark FitzGerald Francois Maltais Jean Bourbeau Roger Goldstein Andrew McIvor Meyer Balter Denis O'Donnell |
| author_facet | Shawn D Aaron Katherine Vandemheen Dean Fergusson Mark FitzGerald Francois Maltais Jean Bourbeau Roger Goldstein Andrew McIvor Meyer Balter Denis O'Donnell |
| author_sort | Shawn D Aaron |
| collection | DOAJ |
| description | BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD). |
| format | Article |
| id | doaj-art-07bba4fa8d6d481c8e0a0cea9232c59f |
| institution | Kabale University |
| issn | 1198-2241 |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-07bba4fa8d6d481c8e0a0cea9232c59f2025-02-03T06:00:12ZengWileyCanadian Respiratory Journal1198-22412004-01-0111858158510.1155/2004/394710The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient RecruitmentShawn D Aaron0Katherine Vandemheen1Dean Fergusson2Mark FitzGerald3Francois Maltais4Jean Bourbeau5Roger Goldstein6Andrew McIvor7Meyer Balter8Denis O'Donnell9The Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, CanadaThe Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, CanadaThe Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, CanadaDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaCentre de recherche, Hôpital Laval, Université Laval, Quebec City, Quebec, CanadaDepartment of Medicine, McGill University, Montreal, Quebec, CanadaDepartment of Medicine, The University of Toronto, Toronto, Ontario, CanadaDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Medicine, The University of Toronto, Toronto, Ontario, CanadaThe Department of Medicine, Queen’s University, Kingston, Ontario, CanadaBACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD).http://dx.doi.org/10.1155/2004/394710 |
| spellingShingle | Shawn D Aaron Katherine Vandemheen Dean Fergusson Mark FitzGerald Francois Maltais Jean Bourbeau Roger Goldstein Andrew McIvor Meyer Balter Denis O'Donnell The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment Canadian Respiratory Journal |
| title | The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment |
| title_full | The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment |
| title_fullStr | The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment |
| title_full_unstemmed | The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment |
| title_short | The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment |
| title_sort | canadian optimal therapy of copd trial design organization and patient recruitment |
| url | http://dx.doi.org/10.1155/2004/394710 |
| work_keys_str_mv | AT shawndaaron thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT katherinevandemheen thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT deanfergusson thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT markfitzgerald thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT francoismaltais thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT jeanbourbeau thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT rogergoldstein thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT andrewmcivor thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT meyerbalter thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT denisodonnell thecanadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT shawndaaron canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT katherinevandemheen canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT deanfergusson canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT markfitzgerald canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT francoismaltais canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT jeanbourbeau canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT rogergoldstein canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT andrewmcivor canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT meyerbalter canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment AT denisodonnell canadianoptimaltherapyofcopdtrialdesignorganizationandpatientrecruitment |